BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17204390)

  • 21. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
    Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH
    J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Costimulatory mechanisms in the elderly.
    Effros RB
    Vaccine; 2000 Feb; 18(16):1661-5. PubMed ID: 10689145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral human CD8(+)CD28(+)T lymphocytes give rise to CD28(-)progeny, but IL-4 prevents loss of CD28 expression.
    Labalette M; Leteurtre E; Thumerelle C; Grutzmacher C; Tourvieille B; Dessaint JP
    Int Immunol; 1999 Aug; 11(8):1327-36. PubMed ID: 10421790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
    McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
    Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India.
    Chandele A; Sewatanon J; Gunisetty S; Singla M; Onlamoon N; Akondy RS; Kissick HT; Nayak K; Reddy ES; Kalam H; Kumar D; Verma A; Panda H; Wang S; Angkasekwinai N; Pattanapanyasat K; Chokephaibulkit K; Medigeshi GR; Lodha R; Kabra S; Ahmed R; Murali-Krishna K
    J Virol; 2016 Dec; 90(24):11259-11278. PubMed ID: 27707928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD151 Expression Is Associated with a Hyperproliferative T Cell Phenotype.
    Seu L; Tidwell C; Timares L; Duverger A; Wagner FH; Goepfert PA; Westfall AO; Sabbaj S; Kutsch O
    J Immunol; 2017 Nov; 199(9):3336-3347. PubMed ID: 28954890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD28 co-stimulation results in down-regulation of lymphotactin expression in human CD4(+) but not CD8(+) T cells via an IL-2-dependent mechanism.
    Olive D; Cerdan C
    Eur J Immunol; 1999 Aug; 29(8):2443-53. PubMed ID: 10458758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-15 preferentially enhances functional properties and antigen-specific responses of CD4+CD28(null) compared to CD4+CD28+ T cells.
    Alonso-Arias R; Moro-García MA; Vidal-Castiñeira JR; Solano-Jaurrieta JJ; Suárez-García FM; Coto E; López-Larrea C
    Aging Cell; 2011 Oct; 10(5):844-52. PubMed ID: 21635686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin 15 is a growth factor for human thymocytes with preferential effect on CD8(+)cells.
    Thulesen S; Nielsen M; Petersen TR; Holst Nissen M; Odum N; Röpke C
    Cytokine; 2000 Jun; 12(6):751-5. PubMed ID: 10843758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.
    Van Gool SW; Zhang Y; Kasran A; de Boer M; Ceuppens JL
    Scand J Immunol; 1996 Jul; 44(1):21-9. PubMed ID: 8693288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aging- and Tumor-Mediated Increase in CD8
    Huff WX; Bam M; Shireman JM; Kwon JH; Song L; Newman S; Cohen-Gadol AA; Shapiro S; Jones T; Fulton K; Liu S; Tanaka H; Liu Y; Wan J; Dey M
    Immunohorizons; 2021 Jun; 5(6):395-409. PubMed ID: 34103370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of CD28 expression on CD8+ T cells by CTLA-4.
    Berg M; Zavazava N
    J Leukoc Biol; 2008 Apr; 83(4):853-63. PubMed ID: 18162511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual roles of IL-15 in maintaining IL-7RalphalowCCR7- memory CD8+ T cells in humans via recovering the phosphatidylinositol 3-kinase/AKT pathway.
    Kim HR; Hwang KA; Kang I
    J Immunol; 2007 Nov; 179(10):6734-40. PubMed ID: 17982063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of CD97 on human lymphocyte subsets and limited effect of CD97 antibodies on allogeneic T-cell stimulation.
    Kop EN; Matmati M; Pouwels W; Leclercq G; Tak PP; Hamann J
    Immunol Lett; 2009 Apr; 123(2):160-8. PubMed ID: 19428565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine deaminase modulation of telomerase activity and replicative senescence in human CD8 T lymphocytes.
    Parish ST; Kim S; Sekhon RK; Wu JE; Kawakatsu Y; Effros RB
    J Immunol; 2010 Mar; 184(6):2847-54. PubMed ID: 20147632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of CD4 and CD8 engagement on the development of cytokine profiles of murine CD4+ and CD8+ T lymphocytes.
    Campbell SB; Komata T; Kelso A
    Immunology; 2000 Mar; 99(3):394-401. PubMed ID: 10712669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD11b expression identifies CD8+CD28+ T lymphocytes with phenotype and function of both naive/memory and effector cells.
    Fiorentini S; Licenziati S; Alessandri G; Castelli F; Caligaris S; Bonafede M; Grassi M; Garrafa E; Balsari A; Turano A; Caruso A
    J Immunol; 2001 Jan; 166(2):900-7. PubMed ID: 11145666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of molecule CD28 and CD38 on CD4⁺/CD8⁺ T lymphocytes in thymus and spleen elicited by Schistosoma japonicum infection in mice model.
    Li N; Ji PY; Song LG; Lei JX; Lv ZY; Wu ZD; Shao X; Sun X
    Parasitol Res; 2015 Aug; 114(8):3047-58. PubMed ID: 26002824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The loss of telomerase activity in highly differentiated CD8+CD28-CD27- T cells is associated with decreased Akt (Ser473) phosphorylation.
    Plunkett FJ; Franzese O; Finney HM; Fletcher JM; Belaramani LL; Salmon M; Dokal I; Webster D; Lawson AD; Akbar AN
    J Immunol; 2007 Jun; 178(12):7710-9. PubMed ID: 17548608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin-Resident Effector Memory CD8
    Li G; Larregina AT; Domsic RT; Stolz DB; Medsger TA; Lafyatis R; Fuschiotti P
    J Invest Dermatol; 2017 May; 137(5):1042-1050. PubMed ID: 28012718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.